Evidence map›Paper›PMID 11565612›Full record

ArticleNeurochemical research2001

Src family kinase involvement in muscarinic receptor-induced tyrosine phosphorylation in differentiated SH-SY5Y cells.

P Watcharasit, J Tucholski, R S Jope

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

P WatcharasitDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 35294-0017, USA.
J Tucholski
R S Jope
University of Alabama at Birmingham · US

Funding

LITHIUM EFFECTS ON CHOLINERGIC ACTIVITYR01MH038752 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JOPE, RICHARD S. · 1985 to 2015
$4.4M
Effects of lithium on cellular signalingR56MH038752 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JOPE, RICHARD S. · 2011 to 2011
$366k
NIMH NIH HHS MH38752
6 · The paper itself

Abstract

Muscarinic receptor-mediated changes in protein tyrosine phosphorylation were examined in differentiated human neuroblastoma SH-SY5Y cells. Treatment of differentiated cells with 1 mM carbachol caused rapid increases in the tyrosine phosphorylation of focal adhesion kinase (FAK), Cas, and paxillin. The src family kinase-selective inhibitor PP1 reduced carbachol-stimulated tyrosine phosphorylation of FAK, Cas, and paxillin by 50 to 75%. In contrast, carbachol-stimulated activation of ERK1/2 was unaffected by PP1. Src family kinase activation by carbachol was further demonstrated by increased carbachol-induced tyrosine phosphorylation of the src-substrate, p120, and tyrosine phosphorylation of the src family kinase activation-associated autophosphorylation site. Site-specific FAK phosphotyrosine antibodies were used to determine that the carbachol-stimulated increase in the autophosphorylation of FAK was unaffected by pretreatment with PP1, whereas the carbachol-stimulated increase in the src family kinase-mediated phosphotyrosine of FAK was completely blocked by pretreatment with PP1. In SH-SY5Y cell lines stably overexpressing Fyn, the phosphotyrosine immunoreactivity of FAK was 625% that of control cells. Thus, muscarinic receptors activate protein tyrosine phosphorylation in differentiated cells, and the tyrosine phosphorylation of FAK, Cas, and paxillin, but not ERK1/2, is mediated by a src family tyrosine kinase activated in response to stimulation of muscarinic receptors.

Indexed as

CarbacholCell DifferentiationCellular Apoptosis Susceptibility ProteinCholinergic AgonistsCytoskeletal ProteinsEnzyme ActivationEnzyme InhibitorsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesHumansNeuronsPaxillinPhenotypePhosphoproteinsPhosphorylationProtein-Tyrosine Kinases4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidineCarbacholCellular Apoptosis Susceptibility ProteinCholinergic AgonistsCytoskeletal ProteinsEnzyme InhibitorsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesPaxillinPhosphoproteinsProtein-Tyrosine KinasesPTK2 protein, humanPXN protein, humanPyrazolesPyrimidinesReceptors, Muscarinicsrc-Family KinasesTyrosine

Identifiers

PMID11565612
OpenAlexW46184420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.